Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 15, 2019

Sun Pharma launches Ezallor Sprinkle in US for people who have difficulty swallowing

Sun Pharmaceutical Industries announced the U.S. launch of Ezallor Sprinkle (rosuvastatin) capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing, a problem that is estimated to affect approximately 30-35% of long-term care residents.

Sun Pharma launches Ezallor Sprinkle in US for people who have difficulty swallowing